What is Vertex Pharmaceuticals's deferred tax assets?

Vertex Pharmaceuticals (VRTX) reported deferred tax assets of $2.95B in Q1 2026.

What does deferred tax assets mean?

Future tax savings expected from accounting and tax reporting differences.

Vertex Pharmaceuticals Deferred Tax Assets increased by 1.7% to $2.95B in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryRisk

SignalContext dependent

VolatilityModerate

First reportedQ3 2019

Last reportedQ4 2025

An increase may signal future tax relief, while a decrease suggests the utilization of tax assets or valuation allowance adjustments.

This represents the future tax benefits that the company expects to realize due to temporary differences between the boo...

Common in global mining; peers with significant capital expenditures often hold substantial deferred tax assets.

Metric ID: non_current_assets_deferred_income_tax_assets_net

2 periods

	Q4 '25	Q1 '26
Value	$2.90B	$2.95B
QoQ Change	—	+1.7%

Range$2.90B – $2.95B

What is Vertex Pharmaceuticals's deferred tax assets?: Vertex Pharmaceuticals (VRTX) reported deferred tax assets of $2.95B in Q1 2026.
What does deferred tax assets mean?: Future tax savings expected from accounting and tax reporting differences.